Clicky

Proteomics International LaboratoriesLtd  (PIQ)

Description: Proteomics International Laboratories Limited is a biological research and drug discovery company. The Company operates in three business units unified by a technology platform: Analytical services, which includes specialist contract research, analytical testing and consultancy; Diagnostics, which includes biomarkers of disease and personalized medicine, and Therapeutics, which includes peptide drug discovery from venoms. The Company focuses on the PromarkerD, a proteomics-derived predictive and diagnostic test for diabetic kidney disease. The Company focuses on its diagnostics portfolio using the Promarker platform, and is investigating proteins associated with endometriosis, mesothelioma and other conditions. The Company has a therapeutic drug discovery program targeting new analgesic (painkilling) and antibiotic drug compounds. The Company also has a laboratory to analyze the make-up of biosimilar drugs as being like-for-like with the brand name drugs they seek to replace.


Keywords: Medicine Biotechnology Clinical Medicine Life Sciences Disease Drugs Drug Discovery Biomarkers Proteins Biosimilar Protein Peptide Pound Personalized Medicine Chemical Pathology Proteomics Endometriosis Laboratory Mesothelioma Diabetic Kidney Disease Medical Signs

Home Page: www.proteomics.com.au

PIQ Technical Analysis

QEII Medical Centre
Perth, WA 6009
Australia
Phone: 61 8 9389 1992


Officers

Name Title
Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London) Co-Founder, MD & Director
Ms. Jacqueline Gray Chief Financial Officer
Mr. Vikesh Malik Chief Commercialisation Officer
Mr. John Chuck Morrison Head of Bus. Devel.
Dr. Scott Bringans Head of Research
Dr. Pearl Tan Head of Logistics
Dr. Kirsten Peters Head of Clinical Studies
Ms. Karen Teresa Logan B.Com., FCIS, BCom, DipAppCorpGov, FFin, ACIS, AGI Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 29.2902
Price-to-Sales TTM: 29.6538
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks